{"id":"https://openalex.org/W4399325784","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e15123","title":"Efficacy and safety of surufatinib combined with EP regimen and serplulimab in first-line treatment of NEC.","display_name":"Efficacy and safety of surufatinib combined with EP regimen and serplulimab in first-line treatment of NEC.","publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4399325784","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e15123"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.e15123","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e15123","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e15123","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100375926","display_name":"Tao\ufffd Zhang","orcid":"https://orcid.org/0000-0003-4018-3393","observed_orcids":["https://orcid.org/0000-0003-4018-3393"]},"institutions":[{"id":"https://openalex.org/I4210129222","display_name":"Wuhan Union Hospital","ror":"https://ror.org/0371fqr87","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129222"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tao Zhang","raw_affiliation_strings":["Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","institution_ids":["https://openalex.org/I4210129222","https://openalex.org/I47720641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101675190","display_name":"Zhenyu Lin","orcid":"https://orcid.org/0000-0002-1733-5806","observed_orcids":["https://orcid.org/0000-0002-1733-5806"]},"institutions":[{"id":"https://openalex.org/I4210129222","display_name":"Wuhan Union Hospital","ror":"https://ror.org/0371fqr87","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129222"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhenyu Lin","raw_affiliation_strings":["Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","institution_ids":["https://openalex.org/I4210129222","https://openalex.org/I47720641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100344057","display_name":"Lei Zhao","orcid":"https://orcid.org/0000-0002-1233-9189","observed_orcids":["https://orcid.org/0000-0002-1233-9189"]},"institutions":[{"id":"https://openalex.org/I4210129222","display_name":"Wuhan Union Hospital","ror":"https://ror.org/0371fqr87","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129222"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lei Zhao","raw_affiliation_strings":["Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","institution_ids":["https://openalex.org/I4210129222","https://openalex.org/I47720641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062898463","display_name":"Hong Ma","orcid":"https://orcid.org/0000-0001-7088-8015","observed_orcids":["https://orcid.org/0000-0001-7088-8015"]},"institutions":[{"id":"https://openalex.org/I4210129222","display_name":"Wuhan Union Hospital","ror":"https://ror.org/0371fqr87","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129222"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hong Ma","raw_affiliation_strings":["Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","institution_ids":["https://openalex.org/I4210129222","https://openalex.org/I47720641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064727229","display_name":"Dejun Zhang","orcid":"https://orcid.org/0000-0001-9129-534X","observed_orcids":["https://orcid.org/0000-0001-9129-534X"]},"institutions":[{"id":"https://openalex.org/I4210129222","display_name":"Wuhan Union Hospital","ror":"https://ror.org/0371fqr87","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129222"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dejun Zhang","raw_affiliation_strings":["Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","institution_ids":["https://openalex.org/I4210129222","https://openalex.org/I47720641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101736245","display_name":"Dandan Yu","orcid":"https://orcid.org/0000-0003-2578-7324","observed_orcids":["https://orcid.org/0000-0003-2578-7324"]},"institutions":[{"id":"https://openalex.org/I4210129222","display_name":"Wuhan Union Hospital","ror":"https://ror.org/0371fqr87","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129222"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dandan Yu","raw_affiliation_strings":["Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","institution_ids":["https://openalex.org/I4210129222","https://openalex.org/I47720641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101971658","display_name":"Min Jin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129222","display_name":"Wuhan Union Hospital","ror":"https://ror.org/0371fqr87","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129222"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Min Jin","raw_affiliation_strings":["Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","institution_ids":["https://openalex.org/I4210129222","https://openalex.org/I47720641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100378656","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0003-1580-1356","observed_orcids":["https://orcid.org/0000-0003-1580-1356","https://orcid.org/0009-0009-7012-5216","https://orcid.org/0000-0002-1980-539X"]},"institutions":[{"id":"https://openalex.org/I4210129222","display_name":"Wuhan Union Hospital","ror":"https://ror.org/0371fqr87","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129222"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":["Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","institution_ids":["https://openalex.org/I4210129222","https://openalex.org/I47720641"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100383973","display_name":"Hongli Liu","orcid":"https://orcid.org/0000-0002-2179-1468","observed_orcids":["https://orcid.org/0000-0002-2179-1468"]},"institutions":[{"id":"https://openalex.org/I4210129222","display_name":"Wuhan Union Hospital","ror":"https://ror.org/0371fqr87","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129222"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongli Liu","raw_affiliation_strings":["Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","institution_ids":["https://openalex.org/I4210129222","https://openalex.org/I47720641"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"e15123","last_page":"e15123"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/surufatinib","display_name":"surufatinib","score":0.8870000243186951},{"id":"https://openalex.org/keywords/serplulimab","display_name":"serplulimab","score":0.968999981880188},{"id":"https://openalex.org/keywords/neuroendocrine-carcinoma","display_name":"neuroendocrine carcinoma","score":0.9509999752044678},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7440000176429749},{"id":"https://openalex.org/keywords/ep-regimen","display_name":"EP regimen","score":0.7300000190734863},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.906000018119812},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5270000100135803},{"id":"https://openalex.org/keywords/vegfr-inhibition","display_name":"VEGFR inhibition","score":0.5860000252723694},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.6790000200271606},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.8289999961853027},{"id":"https://openalex.org/keywords/safety-run-in","display_name":"safety run-in","score":0.4790000021457672},{"id":"https://openalex.org/keywords/dose-expansion","display_name":"dose expansion","score":0.550000011920929},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8759999871253967},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6349999904632568},{"id":"https://openalex.org/keywords/gastrointestinal-neuroendocrine-tumors","display_name":"gastrointestinal neuroendocrine tumors","score":0.7540000081062317},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.31200000643730164},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.32100000977516174}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9122396111488342},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6017498970031738},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44022178649902344},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.438507616519928}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.e15123","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e15123","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e15123","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3172896784","https://openalex.org/W7122667856","https://openalex.org/W4416131848","https://openalex.org/W4391036181","https://openalex.org/W7161034127","https://openalex.org/W3198910780","https://openalex.org/W4296010512","https://openalex.org/W4366352303","https://openalex.org/W4224943531","https://openalex.org/W4399326030"],"abstract_inverted_index":{"e15123":[0],"Background:":[1],"Neuroendocrine":[2],"carcinomas":[3],"(NEC)":[4],"are":[5],"more":[6],"challenging":[7],"than":[8],"neuroendocrine":[9],"tumors":[10,268],"(NET)":[11],"due":[12],"to":[13,32,129,132],"poor":[14,33],"differentiation,":[15],"aggressive":[16],"invasion,":[17],"and":[18,26,75,85,96,115,158,215,224,257,290,328,355,379,389,404],"early":[19],"diagnosis":[20],"difficulties,":[21],"often":[22],"marked":[23],"by":[24,171],"local":[25],"distant":[27],"metastasis":[28],"at":[29,303,341],"diagnosis,":[30],"leading":[31],"outcomes.":[34],"The":[35,190,206,312,391],"ORR":[36],"for":[37,164,305,381],"NEC":[38,382],"as":[39,185,292,383],"first-line":[40,384],"treatment":[41,53,134,261,385],"with":[42,135,143,250,269,363,375],"EP":[43,145,377],"or":[44,182],"EC":[45],"regimens":[46],"is":[47],"approximately":[48],"30%,":[49],"highlighting":[50],"a":[51,56,110,116,165,172,270,293,356,394],"substantial":[52],"gap.":[54],"Surufatinib,":[55],"targeted":[57],"small":[58],"molecule":[59],"kinase":[60],"inhibitor,":[61],"acts":[62],"on":[63,83,200],"vascular":[64,86],"endothelial":[65],"growth":[66,71],"factor":[67,72],"receptors":[68],"(VEGFR-1/2/3),":[69],"fibroblast":[70],"receptor":[73,78],"(FGFR-1),":[74],"colony-stimulating":[76],"factor-1":[77],"(CSF-1R).":[79],"Its":[80],"efficacy":[81,388],"focuses":[82],"anti-angiogenesis":[84],"normalization,":[87],"alongside":[88,402],"its":[89],"role":[90],"in":[91,187,194,308,334],"modulating":[92],"tumor-associated":[93],"macrophages":[94],"(TAMs)":[95],"boosting":[97],"the":[98,121,144,188,195,203,236,279,309,335,364,376],"effectiveness":[99],"of":[100,167,175,192,228,274,299,345,353,361,400],"immunotherapy.":[101],"Methods:":[102],"This":[103],"single-arm,":[104],"open-label,":[105],"multicenter":[106],"clinical":[107],"study":[108,392],"comprised":[109],"safety":[111],"run-in":[112],"(SR)":[113],"phase":[114,174,197,395],"dose-expansion":[117],"(DE)":[118],"phase.":[119,205,238,311],"In":[120],"SR":[122,204,237,280,336],"phase,":[123,281,337],"six":[124,168],"patients":[125],"(pts)":[126],"were":[127,209,255,317],"planned":[128],"be":[130],"enrolled":[131,256,333],"receive":[133],"surufatinib":[136,176,193,300,398],"(250":[137],"mg,":[138],"QD,":[139],"PO,":[140],"Q3W)":[141,157,163],"combined":[142,374],"regimen":[146,378],"(etoposide":[147],"injection:":[148],"100mg/m2,":[149],"d1-3,":[150,155],"IV,":[151,156,162],"Q3W;":[152],"cisplatin:":[153],"25mg/m2,":[154],"serplulimab":[159,178,380],"(300mg,":[160],"d1,":[161],"maximum":[166],"cycles,":[169],"followed":[170],"maintenance":[173],"plus":[177],"until":[179],"disease":[180,357],"progression":[181],"other":[183],"criteria":[184],"specified":[186],"protocol.":[189],"dose":[191,213,399],"DE":[196,310],"was":[198,301],"based":[199],"results":[201,234],"from":[202,235],"primary":[207],"endpoints":[208,219],"recommended":[210,397],"Phase":[211],"2":[212],"(RP2D)":[214],"PFS,":[216],"while":[217],"secondary":[218],"included":[220],"ORR,":[221],"DCR,":[222],"OS,":[223],"safety.":[225,390],"Results:":[226],"As":[227],"December":[229],"27,":[230],"2023,":[231],"this":[232],"reports":[233],"Six":[239],"pts,":[240],"median":[241,271,365],"age":[242],"61.5":[243],"years":[244],"(range":[245,276],"38-70),":[246],"66.7%":[247],"male,":[248],"all":[249],"ECOG":[251],"performance":[252],"status":[253],"1,":[254],"completed":[258],"their":[259],"first":[260],"cycle.":[262],"A":[263],"majority":[264],"(83.3%)":[265],"had":[266],"gastrointestinal-origin":[267],"Ki-67%":[272],"index":[273],"70%":[275],"30%-90%).":[277],"During":[278],"one":[282,343],"patient":[283],"experienced":[284],"Grade":[285],"4":[286],"hematologic":[287],"toxicity":[288,295],"(neutropenia":[289],"leukopenia)":[291],"dose-limiting":[294],"(DLT).":[296],"Consequently,":[297],"RP2D":[298],"established":[302,393],"250mg":[304],"further":[306],"research":[307],"most":[313],"common":[314],"adverse":[315],"events":[316],"neutropenia":[318],"(50%),":[319],"decreased":[320],"white":[321],"blood":[322],"cell":[323],"count":[324],"(33.3%),":[325,327],"fatigue":[326],"diarrhea":[329],"(33.3%).":[330],"Among":[331],"those":[332],"5":[338],"pts":[339],"underwent":[340],"least":[342],"assessment":[344],"efficacy,":[346],"yielding":[347],"an":[348],"objective":[349],"response":[350],"rate":[351,359],"(ORR)":[352],"60%":[354],"control":[358],"(DCR)":[360],"100%,":[362],"progression-free":[366],"survival":[367],"(mPFS)":[368],"not":[369],"yet":[370],"mature.":[371],"Conclusions:":[372],"Surufatinib":[373],"showed":[386],"notable":[387],"II":[396],"250mg,":[401],"immunotherapy":[403],"chemotherapy.":[405],"Clinical":[406],"trial":[407],"information:":[408],"NCT05747729":[409],".":[410]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-06-05T00:00:00"}